Welcome to our dedicated page for Hanover Insuranc SEC filings (Ticker: THG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Hanover Insurance Group, Inc. filings document the regulatory record of a property and casualty insurance holding company with common stock listed on the New York Stock Exchange. Its 8-K reports include results of operations and financial condition, earnings releases and unaudited financial supplements covering underwriting metrics, catastrophe losses, premiums, investment income, book value and related insurance performance measures.
The company’s proxy materials cover annual meeting procedures, shareholder voting matters, board governance and executive compensation disclosures. Other filings record capital-structure activity, including senior unsecured notes, note redemptions, registration-statement references and Form 25 records for the removal of a senior debenture class from exchange listing and registration.
Roche John C reported acquisition or exercise transactions in this Form 4 filing.
HANOVER INSURANCE GROUP, INC. President and CEO John C. Roche reported equity awards tied to the company’s long-term incentive plan. He received an option to buy 45,025 shares of common stock, plus stock-based awards totaling 31,229 shares at no cash cost to him.
Footnotes explain that these grants reflect performance-based restricted stock units from a 2023 award, with performance certified at 150% and 100% of target and vesting on February 27, 2026, as well as new restricted stock units and options that generally vest over three years.
Hanover Insurance Group Executive Vice President Salvatore Bryan J reported equity awards and vesting-related acquisitions of company stock and options. On February 24, 2026, he received a grant of 8,937 common stock options at a price of $0 per share.
He also acquired common shares through performance-based restricted stock units and restricted stock units. These include awards of 2,595, 1,672, and 1,873 common shares, all at $0 per share. Two PBRSU awards granted in 2023 had their performance conditions certified at 150% and 100% of target and remain subject to time-based vesting until February 27, 2026. A separate RSU grant vests on the third anniversary of grant, and the options vest in three equal annual installments.
Hanover Insurance Group Executive Vice President T. Willard Lee reported equity awards under the company’s 2022 Long-Term Incentive Plan. On February 24, 2026, he acquired 3,781 stock options with an exercise right described as a common stock option. These options vest in three equal annual installments on each of the first three anniversaries of the grant date.
On the same date, he also acquired a total of 2,691 shares or units of common stock at no cost in multiple grants. Footnotes explain that earlier performance-based restricted stock units granted on February 27, 2023 had performance conditions certified at 150% and 100% of target, with all such awards remaining subject to time-based vesting and scheduled to vest on February 27, 2026, while another restricted stock unit grant vests on its third anniversary.
The Hanover Insurance Group, Inc. is a Delaware-based holding company focused on U.S. property and casualty insurance sold through independent agents and brokers. For 2025, it generated approximately $6.3 billion in net premiums written, an increase of 3.9% from the prior year.
Business is organized into four segments: Core Commercial, Specialty, Personal Lines and Other. In 2025, Core Commercial wrote $2.3 billion of net premiums, Specialty $1.4 billion, and Personal Lines $2.6 billion, providing a diversified mix across commercial and personal auto, property and liability coverages.
Premiums are geographically concentrated, with Michigan and Massachusetts together representing 26.7% of total net premiums written. The company highlights exposure to catastrophe events, relies on extensive reinsurance (including catastrophe bonds), and carried a GAAP loss and loss adjustment expense reserve of $7.8 billion and investment assets and cash of $11.5 billion at December 31, 2025.
Hanover Insurance Group Executive Vice President Richard W. Lavey reported multiple equity transactions in company common stock. On February 5, 2026, he exercised a stock option for 17,420 shares at an exercise price of $77.91 per share and received common stock.
That same day, he sold several blocks of Hanover common stock at weighted average prices between $178.05 and $179.83, as detailed in the price ranges provided in the notes. He also made a charitable gift of 1,400 shares. Following all reported transactions, he directly owned 30,773.879 Hanover common shares.
An affiliate of THG filed a Rule 144 notice to sell 24,420 shares of common stock, with an aggregate market value of $4,369,097.03. The shares are expected to be sold on or around February 5, 2026 through Fidelity Brokerage Services LLC on the NYSE.
The filing reports that 35,583,964 shares of this class were outstanding. The shares to be sold were acquired mainly through restricted stock vesting in 2022, 2023, and 2025, and through the exercise of a stock option granted on February 23, 2016, with compensation and cash listed as the forms of payment.
The Hanover Insurance Group, Inc. furnished an 8-K to share that it has released its financial results for the quarter ended December 31, 2025. The company issued a press release on February 3, 2026, and also posted unaudited financial information in a Financial Supplement on its website.
The press release is included as Exhibit 99.1 and the unaudited Financial Supplement as Exhibit 99.2, with a cover page interactive data file provided as Exhibit 104.
The Hanover Insurance Group director Jane D. Carlin reported an internal share transfer rather than a new purchase or sale. On January 23, 2026, a total of 3,623 shares of Hanover common stock previously held indirectly under a deferral agreement were reclassified to direct ownership at a stated price of $0. The footnote explains this was a change of ownership from indirect to direct pursuant to the terms of a deferral agreement for stock previously awarded under the company’s 2014 Long-Term Incentive Plan. Following the transaction, Carlin held 3,623 shares directly and 2,306 shares indirectly under the deferral arrangement.
Hanover Insurance Group, Inc. reported that an executive vice president acquired additional common stock through a grant of restricted stock units. On 12/26/2025, the officer received 26.937 shares of common stock at a price of $0, recorded as an acquisition. After this transaction, the officer beneficially owned 25,704.879 shares of common stock in direct ownership. The new RSUs were granted under the company’s 2022 Long-Term Incentive Plan as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the grant date of the original RSUs.
Hanover Insurance Group, Inc. reported an insider equity grant for its President and CEO, who also serves as a director. On 12/26/2025, the executive acquired 134.535 shares of common stock at a price of $0 through restricted stock units under the company’s 2022 Long-Term Incentive Plan. These units were issued as dividend equivalent rights tied to previously granted RSUs and will vest on the third anniversary of the original RSU grant date.
Following this transaction, the executive beneficially owns 123,849.174 shares directly. The filing notes that this total does not include 14,454 shares held by the executive’s spouse.